FDA inspection
Medimmune Pharma B.V.: FDA inspection ending Sep 19, 2019
FDA inspection 1107865 · Nijmegen
Key facts
| Inspection ID | 1107865 |
|---|---|
| Firm | Medimmune Pharma B.V. |
| FEI number | 3003000472 |
| Address | Lagelandseweg 78 |
| City | Nijmegen |
| Fiscal year | 2019 |
| Inspection end date | Sep 19, 2019 |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data